<DOC>
	<DOCNO>NCT00411801</DOCNO>
	<brief_summary>Prior use plasma product , thrombotic thrombocytopenic purpura ( TTP ) usually fatal condition . During plasma exchange therapy , patient need transfusion plasma blood group specific . Transfusing patient incorrect blood group may fatal consequence . Uniplas universally applicable human plasma , administer irrespective patient 's blood group . This study test safety efficacy Uniplas comparison cryosupernatant plasma treatment patient TTP .</brief_summary>
	<brief_title>Safety Efficacy Study Compare Uniplas With Cryosupernatant Plasma Thrombotic Thrombocytopenic Purpura ( TTP )</brief_title>
	<detailed_description />
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombotic Thrombocytopenic</mesh_term>
	<criteria>18 year age . Definite diagnosis acute thrombotic thrombocytopenic purpura ( TTP ) . Thrombocytopenia . Diagnostic sign microangiopathic hemolytic anemia . Congenital thrombotic microangiopathies . Alternative secondary cause microangiopathy . Comorbid illness limit life expectancy le 3 month independent TTP . Patients know HIV positive . Patients know lupus . Refusal accept blood product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>bleed disorder</keyword>
	<keyword>universal plasma</keyword>
	<keyword>plasma</keyword>
	<keyword>plasma exchange</keyword>
</DOC>